Lactobacillus plantarum extracellular metabolites: In vitro assessment of probiotic effects on normal and cancerogenic human cells

International Dairy Journal

Volumn 39, Issue 2, 2014, Pages 293-300

  Dimitrovski, Darko ^a,b   Cencič, Avrelija ^b   Winkelhausen, Eleonora ^a   Langerholc, Tomaž ^b  

^a SS CYRIL AND METHODIUS UNIVERSITY   (Macedonia)

^b UNIVERSITY OF MARIBOR   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

BACILLI; CELL CULTURE; DERMATOLOGY; ONCOLOGY;

ACTIVE COMPONENTS; CELL CYCLE PHASE; EXTRACELLULAR METABOLITES; INFLAMMATORY CONDITIONS; LACTOBACILLUS PLANTARUM; PRO-INFLAMMATORY CYTOKINES; PROLIFERATION TESTS; TRANSEPITHELIAL ELECTRICAL RESISTANCES; HUMAN CELLS; IN-VITRO; PROBIOTICS;

CELLS;

EID: 84907076171     PISSN: 09586946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idairyj.2014.07.009     Document Type: Article

References (32)

1. Asadullah K., Sterry W., Volk H.D. Interleukin-10 therapy - review of a new approach. Pharmacological Reviews 2003, 55:241-269.
2. Bai A.P., Ouyang Q., Zhang W., Wang C.H., Li S.F. Probiotics inhibit TNF-alpha-induced interleukin-8 secretion of HT29 cells. World Journal of Gastroenterology 2004, 10:455-457.
3. Broekaert I.J., Nanthakumar N.N., Walker W.A. Secreted probiotic factors ameliorate enteropathogenic infection in zinc-deficient human Caco-2 and T84 cell lines. Pediatric Research 2007, 62:139-144.
4. Caballero-Franco C., Keller K., De Simone C., Chadee K. The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells. American Journal of Physiology - Gastrointestinal and Liver Physiology 2007, 292:G315-G322.
5. Cencic A., La Bonnardiere C. Trophoblastic interferon-gamma: current knowledge and possible role(s) in early pig pregnancy. Veterinary Research 2002, 33:139-157.
6. Cencic A., Langerholc T. Functional cell models of the gut and their applications in food microbiology - a review. International Journal of Food Microbiology 2010, 141:S4-S14.
7. Federico A., Tuccillo C., Grossi E., Abbiati R., Garbagna N., Romano M., et al. The effect of a new symbiotic formulation on plasma levels and peripheral blood mononuclear cell expression of some pro-inflammatory cytokines in patients with ulcerative colitis: a pilot study. European Review for Medical and Pharmacological Sciences 2009, 13:285-293.
8. Gao Q., Qi L., Wu T., Wang J. An important role of interleukin-10 in counteracting excessive immune response in HT-29 cells exposed to Clostridium butyricum. BMC Microbiology 2012, 12:100.
9. Georgieva R., Iliev I., Haertlé T., Chobert J.-M., Ivanova I., Danova S. Technological properties of candidate probiotic Lactobacillus plantarum strains. International Dairy Journal 2009, 19:696-702.
10. Gewirtz A.T., McCormick B., Neish A.S., Petasis N.A., Gronert K., Serhan C.N., et al. Pathogen-induced chemokine secretion from model intestinal epithelium is inhibited by lipoxin A4 analogs. Journal of Clinical Investigation 1998, 101:1860-1869.
11. Guandalini S. Use of Lactobacillus-GG in paediatric Crohn's disease. Digestive and Liver Disease 2002, 34:S63-S65.
12. Haza A.I., Zabala A., Morales P. Protective effect and cytokine production of a Lactobacillus plantarum strain isolated from ewes' milk cheese. International Dairy Journal 2004, 14:29-38.
13. Hegazy S.K. Effect of probiotics on pro-inflammatory cytokines and NF-κB activation in ulcerative colitis. World Journal of Gastroenterology 2010, 16:4145.
14. Ivec M., Botic T., Koren S., Jakobsen M., Weingartl H., Cencic A. Interactions of macrophages with probiotic bacteria lead to increased antiviral response against vesicular stomatitis virus. Antiviral Research 2007, 75:266-274.
15. Kakisu E., Bolla P., Abraham A.G., de Urraza P., De Antoni G.L. Lactobacillus plantarum isolated from kefir: protection of cultured Hep-2 cells against Shigella invasion. International Dairy Journal 2013, 33:22-26.
16. Klingberg T.D., Pedersen M.H., Cencic A., Budde B.B. Application of measurements of transepithelial electrical resistance of intestinal epithelial cell monolayers to evaluate probiotic activity. Applied and Environmental Microbiology 2005, 71:7528-7530.
17. Lee do K., Jang S., Kim M.J., Kim J.H., Chung M.J., Kim K.J., et al. Anti-proliferative effects of Bifidobacterium adolescentis SPM0212 extract on human colon cancer cell lines. BMC Cancer 2008, 8:310.
18. Ma E.L., Choi Y.J., Choi J., Pothoulakis C., Rhee S.H., Im E. The anticancer effect of probiotic Bacillus polyfermenticus on human colon cancer cells is mediated through ErbB2 and ErbB3 inhibition. International Journal of Cancer 2010, 127:780-790.
19. Malago J.J., Nemeth E., Koninkx J.F., Tooten P.C., Fajdiga S., van Dijk J.E. Microbial products from probiotic bacteria inhibit Salmonella enteritidis 857-induced IL-8 synthesis in Caco-2 cells. Folia Microbiologica 2010, 55:401-408.
20. Molin G. Probiotics in foods not containing milk or milk constituents, with special reference to Lactobacillus plantarum 299v. American Journal of Clinical Nutrition 2001, 73:380S-385S.
21. Nissen L., Chingwaru W., Sgorbati B., Biavati B., Cencic A. Gut health promoting activity of new putative probiotic/protective Lactobacillus spp. strains: a functional study in the small intestinal cell model. International Journal of Food Microbiology 2009, 135:288-294.
22. Ohland C.L., Macnaughton W.K. Probiotic bacteria and intestinal epithelial barrier function. American Journal of Physiology: Gastrointestinal and Liver Physiology 2010, 298:G807-G819.
23. PathogenCombat Final PathogenCombat report Dec. 2011, Available at. http://www.pathogencombat.com/Publications/Final%2520Report.aspx.
24. Reilly N., Poylin V., Menconi M., Onderdonk A., Bengmark S., Hasselgren P.O. Probiotics potentiate IL-6 production in IL-1beta-treated Caco-2 cells through a heat shock-dependent mechanism. American Journal of Physiology: Regulatory, Integrative and Comparative Physiology 2007, 293:R1169-R1179.
25. Rembacken B.J., Snelling A.M., Hawkey P.M., Chalmers D.M., Axon A.T. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 1999, 354:635-639.
26. Sanchez B., Urdaci M.C., Margolles A. Extracellular proteins secreted by probiotic bacteria as mediators of effects that promote mucosa-bacteria interactions. Microbiology 2010, 156:3232-3242.
27. Seth A., Yan F., Polk D.B., Rao R.K. Probiotics ameliorate the hydrogen peroxide-induced epithelial barrier disruption by a PKC- and MAP kinase-dependent mechanism. American Journal of Physiology - Gastrointestinal and Liver Physiology 2008, 294:G1060-G1069.
28. Tao Y., Drabik K.A., Waypa T.S., Musch M.W., Alverdy J.C., Schneewind O., et al. Soluble factors from Lactobacillus GG activate MAPKs and induce cytoprotective heat shock proteins in intestinal epithelial cells. American Journal of Physiology - Cell Physiology 2006, 290:C1018-C1030.
29. Yan F., Cao H., Cover T.L., Washington M.K., Shi Y., Liu L., et al. Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism. Journal of Clinical Investigation 2011, 121:2242-2253.
30. Yan F., Cao H., Cover T.L., Whitehead R., Washington M.K., Polk D.B. Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 2007, 132:562-575.
31. Yan F., Polk D.B. Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. Journal of Biological Chemistry 2002, 277:50959-50965.
32. You H.J., Oh D.K., Ji G.E. Anticancerogenic effect of a novel chiroinositol-containing polysaccharide from Bifidobacterium bifidum BGN4. FEMS Microbiology Letters 2004, 240:131-136.